Clinical trial
Comparison of Voriconazole and Amphotericin B in Treating Patients With…
NCT00003031 · European Organisation for Research and Treatment of Cancer - EORTC, Other · Completed
Key facts
| NCT number | NCT00003031 |
|---|---|
| Title | Comparison of Voriconazole and Amphotericin B in Treating Patients With Aspergillosis |
| Official title | An Open Randomised Comparative Multicentre Study of the Efficacy, Safety and Toleration of Voriconazole Versus Amphotericin-B in the Treatment of Acute Invasive Aspergillosis in Immunocompromised Patients |
| Lead sponsor | European Organisation for Research and Treatment of Cancer - EORTC, Other |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Infection, Pulmonary Complications |
| Intervention type | Drug |
| Interventions | amphotericin B deoxycholate, voriconazole |
| Enrollment | 212 |
| Start date | Jun 1, 1997 |
| Primary completion | Oct 1, 2000 |
| First posted | May 27, 2004 |
| Last update posted | Jul 2, 2012 |
| Countries | Australia, Belgium, France, Germany, Hungary, Ireland, Israel, Italy, Luxembourg, Netherlands, Spain, Sweden and 3 more |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: